Terms: = Liver cancer AND DNAJB1, HSPF1, 3337, ENSG00000132002, P25685, Hdj1, Hsp40 AND Prognosis
9 results:
1. DNAJC8: a prognostic marker and potential therapeutic target for hepatocellular carcinoma.
Zhang Z; Ju M; Tang Z; He Z; Hua S
Front Immunol; 2023; 14():1289548. PubMed ID: 38274804
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
Alshareefy Y; Shen CY; Prekash RJ
Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
[TBL] [Abstract] [Full Text] [Related]
3. dnajb1-PRKACA in HEK293T cells induces LINC00473 overexpression that depends on PKA signaling.
Kim SS; Kycia I; Karski M; Ma RK; Bordt EA; Kwan J; Karki A; Winter E; Aktas RG; Wu Y; Emili A; Bauer DE; Sethupathy P; Vakili K
PLoS One; 2022; 17(2):e0263829. PubMed ID: 35167623
[TBL] [Abstract] [Full Text] [Related]
4. DNAJC5 promotes hepatocellular carcinoma cells proliferation though regulating SKP2 mediated p27 degradation.
Wang H; Luo J; Tian X; Xu L; Zhai Z; Cheng M; Chen L; Luo S
Biochim Biophys Acta Mol Cell Res; 2021 May; 1868(6):118994. PubMed ID: 33662413
[TBL] [Abstract] [Full Text] [Related]
5. BAP1 mutations define a homogeneous subgroup of hepatocellular carcinoma with fibrolamellar-like features and activated PKA.
Hirsch TZ; Negulescu A; Gupta B; Caruso S; Noblet B; Couchy G; Bayard Q; Meunier L; Morcrette G; Scoazec JY; Blanc JF; Amaddeo G; Nault JC; Bioulac-Sage P; Ziol M; Beaufrère A; Paradis V; Calderaro J; Imbeaud S; Zucman-Rossi J
J Hepatol; 2020 May; 72(5):924-936. PubMed ID: 31862487
[TBL] [Abstract] [Full Text] [Related]
6. KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis.
Yang S; Ren X; Liang Y; Yan Y; Zhou Y; Hu J; Wang Z; Song F; Wang F; Liao W; Liao W; Ding Y; Liang L
Oncogene; 2020 Jan; 39(2):249-261. PubMed ID: 31477839
[TBL] [Abstract] [Full Text] [Related]
7. Fibrolamellar Carcinoma: What Is New and Why It Matters.
Graham RP
Surg Pathol Clin; 2018 Jun; 11(2):377-387. PubMed ID: 29751881
[TBL] [Abstract] [Full Text] [Related]
8. Fibrolamellar carcinoma: A histologically unique tumor with unique molecular findings.
Graham RP; Torbenson MS
Semin Diagn Pathol; 2017 Mar; 34(2):146-152. PubMed ID: 28110996
[TBL] [Abstract] [Full Text] [Related]
9. A genomic case study of mixed fibrolamellar hepatocellular carcinoma.
Griffith OL; Griffith M; Krysiak K; Magrini V; Ramu A; Skidmore ZL; Kunisaki J; Austin R; McGrath S; Zhang J; Demeter R; Graves T; Eldred JM; Walker J; Larson DE; Maher CA; Lin Y; Chapman W; Mahadevan A; Miksad R; Nasser I; Hanto DW; Mardis ER
Ann Oncol; 2016 Jun; 27(6):1148-1154. PubMed ID: 27029710
[TBL] [Abstract] [Full Text] [Related]